These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7753966)

  • 21. Effect of repeated ipsapirone treatment on hippocampal excitatory synaptic transmission in the freely behaving rat: role of 5-HT1A receptors and relationship to anxiolytic effect.
    Xu L; Anwyl R; De Vry J; Rowan MJ
    Eur J Pharmacol; 1997 Mar; 323(1):59-68. PubMed ID: 9105877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Daytime Ayahuasca administration modulates REM and slow-wave sleep in healthy volunteers.
    Barbanoj MJ; Riba J; Clos S; Giménez S; Grasa E; Romero S
    Psychopharmacology (Berl); 2008 Feb; 196(2):315-26. PubMed ID: 18030450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypothermic, ACTH, and cortisol responses to ipsapirone in patients with mania and healthy controls.
    Yatham LN; Shiah IS; Lam RW; Tam EM; Zis AP
    J Affect Disord; 1999 Aug; 54(3):295-301. PubMed ID: 10467974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low doses of ipsapirone increase growth hormone but not oxytocin secretion in normal male and female subjects.
    Newman ME; Li Q; Gelfin Y; Van de Kar LD; Lerer B
    Psychopharmacology (Berl); 1999 Jul; 145(1):99-104. PubMed ID: 10445378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ipsapirone challenge in aggressive men shows an inverse correlation between 5-HT1A receptor function and aggression.
    Cleare AJ; Bond AJ
    Psychopharmacology (Berl); 2000 Mar; 148(4):344-9. PubMed ID: 10928305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ipsapirone and 8-OH-DPAT reduce ethanol preference in rats: involvement of presynaptic 5-HT1A receptors.
    Schreiber R; Opitz K; Glaser T; De Vry J
    Psychopharmacology (Berl); 1993; 112(1):100-10. PubMed ID: 7870997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nocturnal plasma melatonin concentrations in healthy volunteers: effect of single doses of d-fenfluramine, paroxetine, and ipsapirone.
    Nathan PJ; Norman TR; Burrows GD
    J Pineal Res; 1996 Sep; 21(2):55-8. PubMed ID: 8912230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central administration of two 5-HT receptor agonists: effect on REM sleep initiation and PGO waves.
    Sanford LD; Ross RJ; Seggos AE; Morrison AR; Ball WA; Mann GL
    Pharmacol Biochem Behav; 1994 Sep; 49(1):93-100. PubMed ID: 7816896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The behavioural responses to 8-OH-DPAT, ipsapirone and the novel 5-HT1A receptor agonist Bay Vq 7813 in the pig.
    Löscher W; Witte U; Fredow G; Traber J; Glaser T
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Sep; 342(3):271-7. PubMed ID: 2149168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of fluoxetine on sleep: a longitudinal, double-blind polysomnographic study of healthy volunteers.
    Vasar V; Appelberg B; Rimón R; Selvaratnam J
    Int Clin Psychopharmacol; 1994 Sep; 9(3):203-6. PubMed ID: 7814830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of postsynaptic 5-HT1A receptors in the anticonflict effect of ipsapirone.
    Przegaliński E; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E
    Neuropharmacology; 1994 Sep; 33(9):1109-15. PubMed ID: 7838324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of two single doses of tramadol on sleep: a randomized, cross-over trial in healthy volunteers.
    Walder B; Tramèr MR; Blois R
    Eur J Anaesthesiol; 2001 Jan; 18(1):36-42. PubMed ID: 11270008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized phase 1 single-dose polysomnography study of ASP8062, a GABA
    Walzer M; Wu R; Ahmad M; Freeman J; Zammit G; Marek GJ
    Psychopharmacology (Berl); 2021 Mar; 238(3):867-876. PubMed ID: 33433644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A placebo-controlled double-blind multicenter trial of two doses of ipsapirone versus diazepam in generalized anxiety disorder.
    Boyer WF; Feighner JP
    Int Clin Psychopharmacol; 1993; 8(3):173-6. PubMed ID: 7903326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Olanzapine increases slow-wave sleep: evidence for blockade of central 5-HT(2C) receptors in vivo.
    Sharpley AL; Vassallo CM; Cowen PJ
    Biol Psychiatry; 2000 Mar; 47(5):468-70. PubMed ID: 10704958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of aerobic exercise on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine and to ipsapirone in untrained healthy subjects.
    Broocks A; Meyer T; Gleiter CH; Hillmer-Vogel U; George A; Bartmann U; Bandelow B
    Psychopharmacology (Berl); 2001 May; 155(3):234-41. PubMed ID: 11432685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Translational evaluation of JNJ-18038683, a 5-hydroxytryptamine type 7 receptor antagonist, on rapid eye movement sleep and in major depressive disorder.
    Bonaventure P; Dugovic C; Kramer M; De Boer P; Singh J; Wilson S; Bertelsen K; Di J; Shelton J; Aluisio L; Dvorak L; Fraser I; Lord B; Nepomuceno D; Ahnaou A; Drinkenburg W; Chai W; Dvorak C; Sands S; Carruthers N; Lovenberg TW
    J Pharmacol Exp Ther; 2012 Aug; 342(2):429-40. PubMed ID: 22570363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct temporal pattern of the effects of the combined serotonin-reuptake inhibitor and 5-HT1A agonist EMD 68843 on the sleep EEG in healthy men.
    Murck H; Frieboes RM; Antonijevic IA; Steiger A
    Psychopharmacology (Berl); 2001 May; 155(2):187-92. PubMed ID: 11401008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of acute and repeated administration of 5-HT1A receptor agonists on 5-HT release in rat brain in vivo.
    Sharp T; McQuade R; Bramwell S; Hjorth S
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Oct; 348(4):339-46. PubMed ID: 7904048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smoking modulates neuroendocrine responses to ipsapirone in patients with panic disorder.
    Broocks A; Bandelow B; Koch K; Bartmann U; Kinkelbur J; Schweiger U; Hohagen F; Hajak G
    Neuropsychopharmacology; 2002 Aug; 27(2):270-8. PubMed ID: 12093600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.